Stephen Harrow

Edinburgh Cancer Centre

Dr Stephen Harrow was appointed as a Consultant Clinical Oncologist at the Edinburgh Cancer Centre in 2021 having previously worked for 12 years as a consultant at the Beatson West of Scotland Cancer Centre. He completed a PhD combining radiation and viro-therapy in high grade glioma prior to completing his specialist clinical oncology training. Dr Harrow then undertook a fellowship in Radiation Oncology with the British Columbia Cancer Agency in Vancouver. At the Edinburgh Cancer Centre Dr Harrow has a busy thoracic and oligometastatic cancer practice delivering both radiotherapy and systemic anti-cancer therapy. He was awarded a National Research Scotland Fellowship from the Chief Scientists office enabling to develop clinical and laboratory research projects. He is a Principal and Chief Investigator on several clinical trials. His research interests are in re-irradiation, radiation induced pneumonitis, smoking cessation, radiomics, drug/radiotherapy combinations (Concorde arm lead) and oligometastatic disease. He has been awarded a 1.8-million-pound grant from the Scottish Government to develop oligometastatic SABR services across Scotland to ensure equity of access for Scottish patients and clinical trial development. He is the Lead for Cancer Innovation for NHS Lothian and is the South East Scotland Scottish Cancer Research Network Lead.